HIGHLIGHTS
- who: Cervical Cancer A Single-Arm and colleagues from the Université catholique de Louvain, Osaka University, Japan have published the research: Ef cacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients, in the Journal: (JOURNAL) of 25/06/2021
- what: This meta-analysis was carried out to evaluate the efficacy and safety of apatinib in advanced or recurrent cervical cancer patients and hoped that the results of this study might provide more options for clinical treatments. The analysis showed a pooled ORR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.